The company said global comparable sales rose 3.4% in the Q4 2023, with all segments posting gains: U.S. 4.3%, International Operated Markets 4.4%, and International Developmental Licensed Markets 0.7%.

1. 01

   The company said global comparable sales rose 3.4% in the Q4 2023, with all segments posting gains: U.S. 4.3%, International Operated Markets 4.4%, and International Developmental Licensed Markets 0.7%.

2. 02

   The company reported that revenues for the full year 2023 rose 10% to $25,493.7 million, operating income rose 24% to $11,646.7 million, and diluted earnings per share rose 39% to $11.56.

3. 03

   The company said that, excluding Accelerating the Arches-related charges of $290 million and software write-off charges of $72 million in fiscal 2023, diluted earnings per share rose 18% to $11.94.

4. 04

   The company said free cash flow for the year 2023, calculated as cash provided by operations of $9,611.9 million less capital expenditures of $2,357.4 million, was $7,254.5 million. In the same year, it repurchased treasury stock for $3,054.3 million and paid common stock dividends of $4,532.8 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.